Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

1,315

Participants

Timeline

Start Date

June 20, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

January 11, 2019

Conditions
Atrial Fibrillation
Interventions
DRUG

Pradaxa®

Dabigatran etexilate

Trial Locations (24)

110

Taipei Medical University Hospital, Taipei

114

Tri-Service General Hospital, Taipei

220

Far Eastern Memorial Hospital, New Taipei City

235

Taipei Medical University-Shuang Ho Hospital, New Taipei City

330

Chang Gung Memorial Hospital(TaoYuan), Taoyuan District

500

Chang-Hua Christian Hospital, Changhua

632

National Taiwan University Hospital Yun-Lin Branch, Yunlin County

704

NCKUH, Tainan City

710

Chi Mei Medical Center, Tainan City

824

E-Da Hospital, Kaohsiung City

10048

National Taiwan University Hospital, Taipei

10449

Mackay Memorial Hospital, Taipei

11217

Taipe Veterans General Hospital, Taipei

40447

China Medical University Hospital, Taichung

40705

Chia-Yi Christian Hospital, Chia-Yi City

Taichung Veterans General Hospital, Taichung

80756

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

83301

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

Unknown

Show Chwan Memorial Hospital, Changhua

Hsinchu MacKay Memorial Hospital, Hsinchu

National Taiwan University Hospital-Hsin-Chu Branch, Hsinchu

Tainan Municipal An-Nan Hospital, Tainan City

Shin Kong International HealthCare Center, Taipei

Taipei Municipal Wanfang Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY